코메딕스 (CRMD) 주가

코메딕스(CRMD)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $7.77 (-0.26%), 시가총액 $0.59B, PER (주가수익비율) 3.48, 52주 최저~최고 $6.25 ~ $16.56.

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.

핵심 지표

• 현재가: $7.77 (-0.26%)
• 시가총액: $0.59B
• PER (주가수익비율): 3.48
• 52주 최저~최고: $6.25 ~ $16.56
• 섹터: Healthcare
• 산업: Biotechnology
• 거래소: NASDAQ

코메딕스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

코메딕스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.5

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 1.53
• 순이익률: 0.45%
• 영업이익률: 0.50%

자주 묻는 질문